-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

652.P1.53 652. MGUS, Amyloidosis, and Other Non-Myeloma Plasma Cell Dyscrasias: Clinical and Epidemiological: Poster I

Symposia: MGUS, Amyloidosis, and Other Non-Myeloma Plasma Cell Dyscrasias: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 7, 2024: 5:30 PM-7:30 PM
Halls G-H (San Diego Convention Center)

Jonathan S. Wall, PhD1*, Stephen J. Kennel, PhD1*, Alan Stuckey, CNMT1*, Bryan Whittle, CNMT2*, Joseph W. Jackson, PhD1*, Angela D. Williams, MS1*, Trevor Hancock, PhD1*, R. Eric Heidel, PhD1*, Muddassir Mehmood, MD2*, Anne Kassira, MD2*, Ronald H. Lands, MD1, Hannah Watson2*, Rebecca Hung, MD, PhD3* and Emily B Martin, PhD1*

1University of Tennessee Health Science Center College of Medicine, Knoxville, TN
2University of Tennessee Medical Center, Knoxville, TN
3Vanderbilt University Medical Center, Nashville, TN

John Hanna, MD1, Ryan Brown, MD1*, Zain Ali Burney, MD1*, Kawther Abdallah, MD1*, Jason Valent, MD2, Christy J. Samaras, DO2, Faiz Anwer, MD2, Jack Khouri, MD2, Louis Williams, MD2, Shahzad Raza, MD2, Willem Van Heeckeren, MD, PhD2* and Sandra Mazzoni, DO2*

1Department of Internal Medicine, Cleveland Clinic, Cleveland, OH
2Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH

Victor H. Jimenez-Zepeda, MD1, Irwindeep Sandhu, MD2*, Michael P. Chu, MD3, Kathryn Rankin4*, Arleigh McCurdy, MD5, Hyra Sapru, MD5, Christopher Cipkar, MD, BSc5*, Edward Koo5*, Benjamin Patrick5*, Sarah Albert5*, Meriem Henia6*, Christopher McCudden7* and Alissa Visram, MD, MPH8

1Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Canada
2University of Alberta, Cross Cancer Institute, Edmonton, AB, Canada
3Department of Medical Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada
4Cancer Care Alberta, Alberta Health Services, Edmonton, AB, Canada
5The Ottawa Hospital, Ottawa, ON, Canada
6University of Ottawa, Ottawa, ON, Canada
7Department of Pathology and Laboratory Medicine, The Ottawa Hospital, Ottawa, ON, Canada
8Division of Hematology, The Ottawa Hospital Research Institute, Ottawa, ON, Canada

Sandra CM Quinn, PhD, BA1* and Danielle Romaniuk2*

1Research and Advocacy, Myeloma UK, Edinburgh, SCO, United Kingdom
2Research and Advocacy, Myeloma UK, Edinburgh, Scotland, United Kingdom

Divaya Bhutani, MD1,2, Rajshekhar Chakraborty, MD2, Suzanne Lentzsch, MD, PhD2,3, Meghan Sise, MD, MS4*, Elizabeth Shelton5*, Emily Simone6*, Naomi Sender7*, Sherley Mejia8* and Shayan Shirazayan9*

1Herbert Irving Comprehensive Cancer Center, Columbia University medical center, New York, NY
2Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY
3Columbia University Irving Medical Center, New York Presbyterian, New York, NY
4Division of Nephrology, Massachusetts General Hospital, Boston, MA
5columbia university medical center, New York
6Columbia University Medical Center, New YorK
7Columbia University, New York, NY
8Mass General Hospital, Boston
9Columbia University Medical Center, New York

Romain Stammler, MD1*, Yannick Dieudonné2*, Florence Delestre3*, Boris Sorin4*, Bertrand Dunogué3*, Silene Knapp5*, Gregoire Martin De Fremont6*, Benjamin Fournier, MD; PhD7*, Anthony Vanjak6*, Veronique Meignin, MD8*, Emilie Corvilain, MD9*, Emmanuel Lafont10*, Thibault Mahevas11*, Laurence Gerard, MD12*, Lionel Galicier13*, Celeste Lebbe14*, Eric Oksenhendler13*, Sylvain Latour15* and David Boutboul, MD, PhD1,16*

1Laboratory of Lymphocyte Activation and Susceptibility to EBV Infection, Imagine Institute, Paris, France
2Strasbourg University Hospital, Strasbourg, FRA
3Internal Medicine, Hopital Cochin Université Paris Cité, Paris, France
4Internal Medicine, Hopital Cochin Université Paris Cité, Paris, FRA
5Hematology, Hopital Cochin, Paris, FRA
6U976 HIPI, Paris, FRA
7Necker Hospital (APHP), Paris, France
8Pathology, Hopital Saint-Louis, PARIS, FRA
9Hôpital Saint-Louis, APHP, Paris, France
10Assistance Publique -hopitaux De Paris, Paris, FRA
11Dermatology, Hôpital Saint Louis, Paris, France
12Hôpital Saint-Louis, Paris, France
13Service d'Immunopathologie Clinique, Saint Louis hospital, AP-HP, Paris, France
14Hopital Saint Louis, Paris, FRA
15Instutut IMAGINE, Hôpital Necker, Paris, FRA
16Department of Hematology, Hôpital Cochin, AP-HP, Université Paris Cité, Paris, France

Uday Yanamandra, MD, DM1,2, Harikrishnan Premdeep, MD3*, J Muthukrishnan, MD4*, Narendra Kotwal5*, Pankaj Malhotra, MD6,7,8, Velu Nair, MBBS, MD9,10 and Shaji Kumar, MD11,12

1Internal Medicine and Hematology, Armed Forces Medical College, Pune, IND
2Internal Medicine and Hematology, Armed Forces Medical College, Pune, India
3INTERNAL MEDICINE, ARMED FORCES MEDICAL COLLEGE, PUNE, India
4Internal Medicine, Armed Forces Medical College, Pune, India
5Armed Forces Medical College, Pune, India
6Postgraduate Institute of Medical Education and Research, Chandigarh, India
7Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
8Department of Clinical Hematology, Postgraduate Institute of Medical Education and Research, Chandigarh, Chandigarh, India
9Apollo Hospitals Ahmedabad, Detrojrampura, Gujarat, India
10Apollo Hospitals Ahmedabad, Detrojrampura, Gujarat, IND
11Division of Hematology, Mayo Clinic, Rochester, MN
12Mayo Clinic, Rochester, MN

Yannick Dieudonné1*, Clement Gourguechon2*, Romain Stammler, MD3*, Florence Delestre4*, Boris Sorin5*, Bertrand Dunogué4*, Guillaume Dumas6*, Guillemette Fouquet, MD, PhD7*, Anne Marie Ronchetti8*, Romain Paule9*, Pascal Meliani10*, Nathalie Pansu11*, Rodolphe Buzele12*, Robin Noel, MD13*, Jehane Fadlallah14*, Emilie Corvilain, MD15*, Marion Malphettes16*, Laurence Gerard, MD17*, Veronique Meignin18*, Constance Guillaud19*, Antoine Dossier20*, Jeremie Dion21*, Eric Oksenhendler14*, Lionel Galicier22* and David Boutboul, MD, PhD3,23*

1Strasbourg University Hospital, Strasbourg, FRA
2Amiens University Hospital, Amiens, France
3Department of Hematology, Hôpital Cochin, AP-HP, Université Paris Cité, Paris, France
4Internal Medicine, Hopital Cochin Université Paris Cité, Paris, France
5Internal Medicine, Hopital Cochin Université Paris Cité, Paris, FRA
6Intensive Care Unit, CHU Grenoble, Grenoble, France
7Hematology Department, Hospital Sud Francilien, Corbeil-Essonnes, France
8CH Sud Francilien, Hematology Department, Corbeil Essonne, France
9Hopital Foch, Suresnes, FRA
10CH Mayotte, Mayotte, France
11Tropical and Infectious Diseases University Hospital, Montpellier Cedex 5, Franc, Montpellier, FRA
12Centre Hospitalier de Saint-Brieuc, Saint-Brieuc, France
13Institut Paoli-Calmettes, Marseille, FRA
14Service d'Immunopathologie Clinique, Saint Louis hospital, AP-HP, Paris, France
15Hôpital Saint-Louis, APHP, Paris, France
16Saint Louis Hospital, Paris, France
17Hôpital Saint-Louis, Paris, France
18Assistance Publique - Hôpitaux de Paris (APHP), Pathology; Paris University. Paris, Paris, France
19Hôpital Henri Mondor, Créteil, France
20Internal Medicine, Hôpital Bichat, Paris, France
21Toulouse University Hospital, Toulouse, France
22Centre de Réference National Maladie de Castleman, Paris, France
23Laboratory of Lymphocyte Activation and Susceptibility to EBV Infection, Imagine Institute, Paris, France

Louis Williams, MD1, Danai Dima, MD2, Hanny Sawaf, MD3*, Ali Mehdi, MD, M.Ed.3*, Daniel Cancilla, MD4, Hira Shaikh, MD5, Faiz Anwer, MD6, Sandra Mazzoni, DO7, Beth M. Faiman, PhD, CNP6, Jack Khouri, MD6, Christy J. Samaras, DO8, Jason Valent, MD6 and Shahzad Raza, MD6

1Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
2University of Washington, Seattle, WA
3Cleveland Clinic Foundation, Cleveland, OH
4Blood and Marrow Transplant Program, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH
5University of Iowa Caver College of Medicine, Coralville, IA
6Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
7Department of Hematology and Medical Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH
8Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland

Hassan Kawtharany1*, Muayad Azzam, MD2*, Jamil Nazzal, MD1*, Vishal Kukreti, MD, MSc3, Matthew D. Seftel, MD, FRCP, FRCPC, MPH4, Qais Hamarsha, MD1*, Aseel Alkhader, MD1*, Tala Khraise, MD5*, Mohammad Mahmoud AlMasri, MD6*, Hadi Khaled Abou Zeid, MD7*, Iktimal Alwan, MD8*, Mhd Amin Alzabibi, MD9*, Noor Jaber1*, Laura Darwish10*, Faizi Jamal, MD11*, Noel Dasgupta, MD12*, Nitasha Sarswat, MD13*, Alfredo H. De La Torre, MD14, Maria Adela Aguirre, MD, PhD15*, Deborah Boedicker16*, Naresh Bumma, MD17, Antonia Carroll, MD18*, Raymond Comenzo, MD19, Joselle Cook, MBBS20, Angela Dispenzieri, MD20, Jack Khouri, MD21, Maria M. Picken, MD, PhD22*, Shahzad Raza, MD21, Nelson Leung, MD20, Vaishali Sanchorawala23, Hira Shaikh, MD24, Daulath Singh, MD25* and Reem A Mustafa, MD, PhD, MPH26*

1Evidence-Based Practice and Impact Center, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS
2Evidence-Based Practice and Impact Center, Department of Internal Medicine, University of Kansas Medical Center, Overland Park, KS
3Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
4Department of Medicine, University of British Columbia, Vancouver, CAN
5Northwest Health, Porter County, IN
6King Hussein Cancer Center, Amman, Jordan
7University of Balamand, Balamand, Lebanon
8AdventHealth, Tampa
9Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden
10Blue Valley Southwest, Kansas city
11Division of Cardiology, Department of Medicine, City of Hope National Medical Center, Duarte, CA
12Indiana University School of Medicine, Indianapolis, IN
13Advanced Heart Failure, Mechanical Circulatory Support and Transplantation, Division of Cardiology, The University of Chicago, Chicago, IL
14QEII Health Sciences Centre, Halifax, NS, CAN
15Internal Medicine Department, Hospital Italiano de Buenos Aires, BUENOS AIRES, AL, ARG
16Mackenzie’s Mission, Great Falls, VA
17The Ohio State University Comprehensive Cancer Center, COLUMBUS, OH
18Department of Neurology and Neurophysiology, St Vincent’s Hospital, Sydney, AUS
19Tufts Medical Center, Boston, MA
20Division of Hematology, Mayo Clinic, Rochester, MN
21Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
22Loyola University Medical Center, Maywood, IL
23Section of Hematology and Medical Oncology, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA
24Division of Hematology, Oncology and Bone Marrow Transplantation, University of Iowa, Coralville, IA
25Mission Cancer + Blood, Des Moines, IA
26Division of Nephrology and Hypertension, Department of Internal Medicine, University of Kansas Medical Centre, Kansas City, KS

Muayad Azzam, MD1*, Hassan Kawtharany2*, Jamil Nazzal, MD2*, Vishal Kukreti, MD, MSc3, Matthew D. Seftel, MD, FRCP, FRCPC, MPH4, Aseel Alkhader, MD2*, Qais Hamarsha, MD2*, Tala Khraise, MD5*, Mohammad Mahmoud AlMasri, MD6*, Hadi Khaled Abou Zeid, MD7*, Iktimal Alwan, MD8*, Noor Jaber2*, Mohammad Fraitekh9*, Noel Dasgupta, MD10*, Raymond Comenzo, MD11, Faizi Jamal, MD12*, Maria Adela Aguirre, MD, PhD13*, Deborah Boedicker14*, Naresh Bumma, MD15, Antonia Carroll, MD16*, Joselle Cook, MBBS17, Alfredo H. De La Torre, MD18, Angela Dispenzieri, MD17, Jack Khouri, MD19, Nelson Leung, MD17, Maria M. Picken, MD, PhD20*, Shahzad Raza, MD19, Vaishali Sanchorawala21, Hira Shaikh, MD22, Nitasha Sarswat, MD23*, Daulath Singh, MD24* and Reem A Mustafa, MD, PhD, MPH25*

1Evidence-Based Practice and Impact Center, Department of Internal Medicine, University of Kansas Medical Center, Overland Park, KS
2Evidence-Based Practice and Impact Center, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS
3Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
4Department of Medicine, University of British Columbia, Vancouver, CAN
5Northwest Health, Porter County, IN
6King Hussein Cancer Center, Amman, Jordan
7University of Balamand, Balamand, Lebanon
8AdventHealth, Tampa
9Blue Valley West, Overland Park, KS
10Indiana University, Bloomington, IN
11Division of Hematology/Oncology, John C. Davis Myeloma and Amyloid Program, Tufts Medical Center, Boston, MA
12Division of Cardiology, Department of Medicine, City of Hope National Medical Center, Duarte, CA
13Internal Medicine Department, Hospital Italiano de Buenos Aires, BUENOS AIRES, AL, ARG
14Mackenzie’s Mission, Great Falls, VA
15The Ohio State University Comprehensive Cancer Center, COLUMBUS, OH
16Department of Neurology and Neurophysiology, St Vincent’s Hospital, Sydney, AUS
17Division of Hematology, Mayo Clinic, Rochester, MN
18QEII Health Sciences Centre, Halifax, NS, CAN
19Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
20Loyola University Medical Center, Maywood, IL
21Amyloidosis Center, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA
22Division of Hematology, Oncology and Bone Marrow Transplantation, University of Iowa, Coralville, IA
23Advanced Heart Failure, Mechanical Circulatory Support and Transplantation, Division of Cardiology, The University of Chicago, Chicago, IL
24Mission Cancer + Blood, Des Moines, IA
25Division of Nephrology and Hypertension, Department of Internal Medicine, University of Kansas Medical Centre, Kansas City, KS

Alexa Loncharich, MD1, Mark Fiala, PhD2*, Julie Fortier, PhD2*, Keith Stockerl-Goldstein, MD3, Ravi Vij, MD, MBA3, Mark A. Schroeder, MD3, Mark Zaydman, MD, PhD4, Michael Slade, MD, MS3 and Mariya Liyasova, PhD5*

1Washington University School of Medicine in St. Louis, St Louis, MO
2Division of Oncology, Washington University School of Medicine, Saint Louis, MO
3Division of Oncology, Washington University School of Medicine, St. Louis, MO
4Division of Pathology, Washington University School of Medicine, St Louis, MO
5Rapid Novor Inc., Kitchener, ON, Canada

Abdullah Faisal Deen1*, Qaiser Bashir, MD1, Neeraj Y. Saini, MD1, Yosra M. Aljawai, MD, MS2, Chitra Hosing, MD1, Uday Popat, MD1, Melody R. Becnel, MD3, Gregory P. Kaufman, MD3*, Sheeba K. Thomas, MD3, Donna M. Weber, MD4, Robert Z. Orlowski, MD, PhD4, Elizabeth J. Shpall, MD1, Richard E. Champlin, MD1, Muzaffar H. Qazilbash, MD1 and Samer A. Srour, MD1

1Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
2The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Sophiya S Sami1*, Qaiser Bashir, MD1, Neeraj Y. Saini, MD1, Yosra M. Aljawai, MD, MS1, Chitra Hosing, MD1, Uday Popat, MD1, Melody R. Becnel, MD2, Gregory P. Kaufman, MD2*, Sheeba K. Thomas, MD2, Donna M. Weber, MD2, Robert Z. Orlowski, MD, PhD2, Richard E. Champlin, MD1, Elizabeth J. Shpall, MD1, Muzaffar H. Qazilbash, MD1 and Samer A. Srour, MD1

1Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Omer Ashruf1*, Ali Mushtaq, MD2*, Faiza Zakaria, MBBS3*, Razwana Khanam, MD4* and Faiz Anwer, MD5

1College of Medicine, Northeast Ohio Medical University, Solon, OH
2Department of Internal Medicine, Cleveland Clinic, Cleveland, OH
3Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan
4Department of Hematology & Oncology, Medical University of South Carolina, Charleston, SC
5Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH

Jamil Nazzal, MD1*, Muayad Azzam, MD2*, Hassan Kawtharany3*, Vishal Kukreti, MD, MSc4, Matthew D. Seftel, MD, FRCP, FRCPC, MPH5,6, Aseel Alkhader, MD3*, Tala Khraise, MD7*, Qais Hamarsha, MD3*, Hadi Khaled Abou Zeid, MD8*, Iktimal Alwan, MD9*, Mohammad Mahmoud AlMasri, MD10*, Noor Jaber3*, Vaishali Sanchorawala11, Joselle Cook, MBBS12, Jack Khouri, MD13, Angela Dispenzieri, MD12, Maria M. Picken, MD, PhD14*, Maria Adela Aguirre, MD, PhD15*, Hira Shaikh, MD16, Shahzad Raza, MD17, Antonia Carroll, MD18*, Deborah Boedicker19*, Naresh Bumma, MD20, Raymond Comenzo, MD21, Noel Dasgupta, MD22*, Daulath Singh, MD23*, Alfredo H. De La Torre, MD24, Nitasha Sarswat, MD25*, Nelson Leung, MD12, Faizi Jamal, MD26* and Reem A Mustafa, MD, PhD, MPH27*

1Evidence-Based Practice and Impact Center, Department of Internal Medicine, University of Kansas Medical Center, KANSAS CITY, AL
2Evidence-Based Practice and Impact Center, Department of Internal Medicine, University of Kansas Medical Center, Overland Park, KS
3Evidence-Based Practice and Impact Center, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS
4Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
5CancerCare, Vancouver, BC, Canada
6Department of Medicine, University of British Columbia, Vancouver, CAN
7Northwest Health, Porter County, IN
8University of Balamand, Balamand, Lebanon
9AdventHealth, Tampa
10King Hussein Cancer Center, Amman, Jordan
11Section of Hematology and Medical Oncology, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA
12Division of Hematology, Mayo Clinic, Rochester, MN
13Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
14Loyola University Medical Center, Maywood, IL
15Internal Medicine Department, Hospital Italiano de Buenos Aires, BUENOS AIRES, AL, ARG
16Division of Hematology, Oncology and Bone Marrow Transplantation, University of Iowa, Coralville, IA
17Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Overland Park, KS
18Department of Neurology and Neurophysiology, St Vincent’s Hospital, Sydney, AUS
19Mackenzie’s Mission, Great Falls, VA
20The Ohio State University Comprehensive Cancer Center, COLUMBUS, OH
21Tufts Medical Center, Boston, MA
22Indiana University, Bloomington, IN
23Mission Cancer + Blood, Des Moines, IA
24QEII Health Sciences Centre, Halifax, NS, CAN
25Advanced Heart Failure, Mechanical Circulatory Support and Transplantation, Division of Cardiology, The University of Chicago, Chicago, IL
26Division of Cardiology, Department of Medicine, City of Hope National Medical Center, Duarte, CA
27Division of Nephrology and Hypertension, Department of Internal Medicine, University of Kansas Medical Centre, Kansas City, KS

Hassan Kawtharany1*, Muayad Azzam, MD2*, Jamil Nazzal, MD1*, Vishal Kukreti, MD, MSc3, Matthew D. Seftel, MD, FRCP, FRCPC, MPH4, Qais Hamarsha, MD1*, Aseel Alkhader, MD1*, Tala Khraise, MD5*, Mohammad Mahmoud AlMasri, MD6*, Hadi Khaled Abou Zeid, MD7*, Iktimal Alwan, MD8*, Mhd Amin Alzabibi, MD9*, Noor Jaber1*, Alfredo H. De La Torre, MD10, Noel Dasgupta, MD11*, Nitasha Sarswat, MD12*, Faizi Jamal, MD13*, Maria Adela Aguirre, MD, PhD14*, Deborah Boedicker15*, Naresh Bumma, MD16, Antonia Carroll, MD17*, Raymond Comenzo, MD18, Joselle Cook, MBBS19, Angela Dispenzieri, MD19, Jack Khouri, MD20, Maria M. Picken, MD, PhD21*, Shahzad Raza, MD20, Nelson Leung, MD19, Vaishali Sanchorawala22, Hira Shaikh, MD23, Daulath Singh, MD24* and Reem A Mustafa, MD, PhD, MPH25*

1Evidence-Based Practice and Impact Center, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS
2Evidence-Based Practice and Impact Center, Department of Internal Medicine, University of Kansas Medical Center, Overland Park, KS
3Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
4Department of Medicine, University of British Columbia, Vancouver, CAN
5Northwest Health, Porter County, IN
6King Hussein Cancer Center, Amman, Jordan
7University of Balamand, Balamand, Lebanon
8AdventHealth, Tampa
9Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden
10QEII Health Sciences Centre, Halifax, NS, CAN
11Indiana University School of Medicine, Indianapolis, IN
12Advanced Heart Failure, Mechanical Circulatory Support and Transplantation, Division of Cardiology, The University of Chicago, Chicago, IL
13Division of Cardiology, Department of Medicine, City of Hope National Medical Center, Duarte, CA
14Internal Medicine Department, Hospital Italiano de Buenos Aires, BUENOS AIRES, AL, ARG
15Mackenzie’s Mission, Great Falls, VA
16The Ohio State University Comprehensive Cancer Center, COLUMBUS, OH
17Department of Neurology and Neurophysiology, St Vincent’s Hospital, Sydney, AUS
18Tufts Medical Center, Boston, MA
19Division of Hematology, Mayo Clinic, Rochester, MN
20Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
21Loyola University Medical Center, Maywood, IL
22Section of Hematology and Medical Oncology, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA
23Division of Hematology, Oncology and Bone Marrow Transplantation, University of Iowa, Coralville, IA
24Mission Cancer + Blood, Des Moines, IA
25Division of Nephrology and Hypertension, Department of Internal Medicine, University of Kansas Medical Centre, Kansas City, KS

Efstathios Kastritis, MD, PhD1*, Giovanni O. Palladini, MD, PhD2, Meletios-Athanasios Dimopoulos1, Arnaud Jaccard, MD, PhD3*, Giampaolo Merlini, MD, PhD2*, Foteini Theodorakakou, MD1*, Despina Fotiou, MD1*, Monique C Minnema4*, Ashutosh D. Wechalekar, MBBS, DM, FRCP, FRCPath5, Stavros Golfinopoulos, MD, MSc, MBA6*, Nasia Antoniou, MSc, PhD6*, Giorgos Psarros, MSc6*, Pieter Sonneveld, MD7 and Stefan Schonland8*

1Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
2Amyloidosis Research and Treatment Center, University of Pavia, Pavia, Italy
3Referral Center for AL Amyloidosis, Limoges, France
4Department of Hematology, University Medical Center Utrecht, Utrecht, Netherlands
5Clinical Haematology, Cancer Division, University College London Hospital, London, United Kingdom
6Health Data Specialists, Dublin, Ireland
7Erasmus MC Cancer Institute, Rotterdam, Netherlands
8Medical Department V, Amyloidosis Center, University of Heidelberg, Heidelberg, Germany

*signifies non-member of ASH